Product Information
VIBERZI 75 MG TABLET is a brand product labeled by Allergan, Inc., priced at $28.1203 per EA under NDC 61874007560. Its NADAC has been published 544 times since Mar 23, 2016.
FDA first approved this application on May 27, 2015.
Strength
75 mg/1
Manufacturer
Allergan, Inc.NDC
61874007560
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ELUXADOLINEApproval Type
New Drug (NDA)
FDA Application
NDA206940FDA Approved
5/27/2015
On Market Since
10/1/2015
Pharmacological Classes
Price Statistics
The NADAC for VIBERZI 75 MG TABLET has been published 544 times since Mar 23, 2016, and over the history we have for it it has risen 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.1203 per EA |
|---|---|
| All-time high | $28.1384 (May 13, 2026) |
| All-time low | $15.4825 (Apr 20, 2016) |
| 52-week high | $28.1384 |
| 52-week low | $26.7985 |
| Median price | $22.1052 |
| Average price | $21.8628 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 544 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Eluxadoline market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VIBERZI 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIBERZI 75 MG TABLET, manufactured by Allergan, Inc., is $28.1203 per EA (NDC 61874007560), effective Aug 19, 2026.
How has the price of VIBERZI 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for VIBERZI 75 MG TABLET has risen 80.5%. It has been tracked across 544 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for VIBERZI 75 MG TABLET?
Since Mar 23, 2016, the NADAC for VIBERZI 75 MG TABLET has ranged from a low of $15.4825 (Apr 20, 2016) to a high of $28.1384 (May 13, 2026), with a median of $22.1052 per EA.
Are there cheaper alternatives to VIBERZI 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VIBERZI 75 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIBERZI 75 MG TABLET?
VIBERZI 75 MG TABLET (NDC 61874007560) is labeled by Allergan, Inc., and CMS classifies it as a brand product.